Cardiorespiratory/Metabolic Laboratory, The University of Memphis, Memphis, TN 38152, USA.
Lipids Health Dis. 2011 Feb 10;10:29. doi: 10.1186/1476-511X-10-29.
Licorice flavonoid oil (LFO) has been reported to minimize visceral adipose tissue gain in obese mice and to result in a decrease in body weight and body fat in humans; the effects of which may be more pronounced when administered in an overfed state.
We investigated the effects of LFO in two separate studies. Study 1 included a sample of overweight or grade I-II obese men and women (N = 22) who followed their usual dietary and physical activity programs. Study 2 included a sample of athletic men who followed their usual dietary and physical activity programs but consumed a daily supplemental meal (25% above daily energy requirements) in an attempt to induce a state of overfeeding. In both studies, subjects were randomly assigned (double-blind) to either LFO or a placebo for eight weeks, and anthropometric and multiple biochemical outcomes (e.g., markers of oxidative stress, markers of insulin sensitivity, blood lipids, etc.) were obtained before and following the intervention.
No differences of statistical significance were noted between LFO and placebo for any measured variable in Study 1 or Study 2. When investigating the percent change from baseline for data in Study 2, although not of statistical significance, subjects in the LFO condition experienced less overall fat gain, as well as attenuation in the elevation in selected blood lipids (e.g., cholesterol, LDL-C, and triglycerides).
These combined data indicate little effect of LFO supplementation within a sample of overweight/obese men and women or athletic men, with the possible exception of attenuation in body fat gain and selected components of the blood lipid panel in response to an overfeeding condition.
甘草类黄酮油(LFO)已被报道可减少肥胖小鼠内脏脂肪组织的增加,并导致人体体重和体脂肪的减少;当在过度喂养状态下给药时,其效果可能更为明显。
我们在两项独立的研究中调查了 LFO 的作用。研究 1 包括超重或 I-II 级肥胖的男性和女性(N=22),他们遵循常规的饮食和体育活动计划。研究 2 包括遵循常规饮食和体育活动计划但每天额外摄入一顿(超过每日能量需求的 25%)以试图诱导过度喂养状态的运动员男性。在这两项研究中,受试者被随机分配(双盲)接受 LFO 或安慰剂治疗八周,在干预前后测量了人体测量学和多种生化指标(例如,氧化应激标志物、胰岛素敏感性标志物、血脂等)。
在研究 1 或研究 2 中,LFO 与安慰剂之间在任何测量变量上均无统计学差异。当研究 2 中从基线的百分比变化数据时,虽然没有统计学意义,但 LFO 组的受试者整体脂肪增加较少,并且一些血液脂质(如胆固醇、LDL-C 和甘油三酯)的升高也有所减弱。
这些综合数据表明,LFO 补充剂对超重/肥胖男性和女性或运动员的影响很小,除了在过度喂养状态下对体脂肪增加和部分血脂指标的减弱。